Intraoperative Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Public ClinicalTrials.gov record NCT02685605. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter Randomized Phase III Trial on INTraoperative RAdiotherapy in Newly Diagnosed GliOblastoma Multiforme (INTRAGO II)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
INTRAGO II resembles a multicentric, prospective, randomized, 2-arm, open-label clinical phase III trial which tests if the median progression-free survival (PFS) of patients with newly diagnosed glioblastoma multiforme (GBM) can be improved by the addition of intraoperative radiotherapy (IORT) to standard radiochemotherapy.
Study identification
- NCT ID
- NCT02685605
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 314 participants
Conditions and interventions
Conditions
Interventions
- Standard surgery Procedure
- Intraoperative radiotherapy Radiation
- Radiochemotherapy Radiation
- Temozolomide Drug
Procedure · Radiation · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 8, 2016
- Primary completion
- Oct 31, 2025
- Completion
- May 31, 2026
- Last update posted
- Oct 13, 2025
2016 – 2026
United States locations
- U.S. sites
- 5
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barrow Neurological Institute (SJHMC) | Phoenix | Arizona | 85013 | — |
| Stritch School of Medicine Loyola University | Maywood | Illinois | 60153 | — |
| Long Island Jewish Medical Center, North Shore University Hospital | Lake Success | New York | 11042 | — |
| Lenox Hill Hospital, Hofstra Northwell School of Medicine | New York | New York | 10028 | — |
| West Virginia University | Morgantown | West Virginia | 26506-9260 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02685605, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 13, 2025 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02685605 live on ClinicalTrials.gov.